Stem Cells Intended for Cosmetic Use Only: Regulation in Belgium, Europe and the United States

DSpace/Manakin Repository

Stem Cells Intended for Cosmetic Use Only: Regulation in Belgium, Europe and the United States

Show simple item record

dc.contributor.advisor Peter Hutt en_US
dc.contributor.author Panis, Sarah
dc.date.accessioned 2012-05-18T18:12:26Z
dc.date.issued 2011
dc.identifier.citation Sarah Panis, Stem Cells Intended for Cosmetic Use Only: Regulation in Belgium, Europe and the United States (April 2011). en_US
dc.identifier.uri http://nrs.harvard.edu/urn-3:HUL.InstRepos:8784344
dc.description.abstract The central question in this paper is whether it is wise to assume that cosmetics are not hazardous, especially in the light of the stem cell hype. Some cosmetics contain stem cell extracts or claim to influence the stem cells in the skin. This paper examines the issue of these “stem cell creams” in three jurisdictions: Belgium, Europe and the United States. The paper approaches the issues raised by the advent of such products in the following manner: first, the classification problem is discussed. Stem cell creams sometimes fall in a grey area between cosmetics and drugs. When the categorization is only based on claims made of the products, manufacturers can easily evade their responsibilities by manipulating the claims. The applicable regulations are then analyzed. Although the requirements for drugs are similar in the three jurisdictions, this is not the case with respect to cosmetics. Cosmetics are clearly regulated more strictly in Europe. Finally, a clear overview of the loopholes in the current regulations is offered and some recommendations for change are proposed. The conclusion of the paper is that the discussed stem cell creams might be hazardous and therefore, should be rigorously regulated. Moreover, something as superficial as claims by manufacturer should not be determinative so as to alter the classification of a product. The European model could thus arguably be an inspiration for FDA to base future reforms upon. en_US
dash.license LAA
dc.subject Cosmetics en_US
dc.subject.other Food and Drug Law en_US
dc.title Stem Cells Intended for Cosmetic Use Only: Regulation in Belgium, Europe and the United States en_US
dc.type Paper (for course/seminar/workshop) en_US
dc.date.available 2012-05-18T18:12:26Z

Files in this item

Files Size Format View
Panis, Sarah - ... Law Paper April 4 2011.pdf 298.4Kb PDF View/Open

This item appears in the following Collection(s)

Show simple item record

 
 

Search DASH


Advanced Search
 
 

Submitters